{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:12:56Z","timestamp":1778908376143,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tox.2026.154466","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:04:10Z","timestamp":1774883050000},"page":"154466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of HepaRG mono- and HepaRG:THP-1 cocultures as immune responsive hepatotoxicity models"],"prefix":"10.1016","volume":"524","author":[{"given":"Gijs J.J.","family":"van Slobbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-8921","authenticated-orcid":false,"given":"Mathias","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-111X","authenticated-orcid":false,"given":"Wouter","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen","family":"Govers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Bouwmeester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.tox.2026.154466_bib1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2026.154466_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.toxlet.2016.06.008","article-title":"Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-\u03b1","volume":"258","author":"Al-Attrache","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2026.154466_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152856","article-title":"Derivation, characterisation and analysis of an adverse outcome pathway network for human hepatotoxicity","volume":"459","author":"Arnesdotter","year":"2021","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2133\/dmpk.DMPK-10-RV-089","article-title":"Role of Biotransformation in Drug-Induced Toxicity: Influence of Intra- and Inter-Species Differences in Drug Metabolism","volume":"26","author":"Baillie","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.28323","article-title":"Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports","volume":"63","author":"Bj\u00f6rnsson","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2026.154466_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110536","article-title":"Investigations of acute effects of polystyrene and polyvinyl chloride micro- and nanoplastics in an advanced in vitro triple culture model of the healthy and inflamed intestine","volume":"193","author":"Busch","year":"2021","journal-title":"Environ. Res."},{"issue":"10","key":"10.1016\/j.tox.2026.154466_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1124\/dmd.122.000926","article-title":"Physiologically Based Pharmacokinetic Modeling To Predict Drug-Biologic Interactions with Cytokine Modulators: Are These Relevant and Is Interleukin-6 Enough?","volume":"50","author":"Chen","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: Interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2026.154466_bib9","unstructured":"Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C., & Tong, W. (2023, February 9). Drug Induced Liver Injury Rank (DILIrank) Dataset. \u3008Https:\/\/Www.Fda.Gov\/Science-Research\/Liver-Toxicity-Knowledge-Base-Ltkb\/Drug-Induced-Liver-Injury-Rank-Dilirank-Dataset\u3009."},{"issue":"7","key":"10.1016\/j.tox.2026.154466_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/138920012802138589","article-title":"De-Risking Bio-therapeutics for Possible Drug Interactions Using Cryopreserved Human Hepatocytes","volume":"13","author":"Dallas","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tox.2026.154466_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxlet.2022.06.004","article-title":"Hepatic bile acid synthesis and secretion: Comparison of in vitro methods","volume":"365","author":"de Bruijn","year":"2022","journal-title":"Toxicol. Lett."},{"issue":"12","key":"10.1016\/j.tox.2026.154466_bib12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1124\/dmd.124.001867","article-title":"CYP P450 and non-CYP P450 Drug Metabolizing Enzyme Families Exhibit Differential Sensitivities towards Proinflammatory Cytokine Modulation","volume":"52","author":"de Jong","year":"2024","journal-title":"Drug Metab. Dispos."},{"issue":"19","key":"10.1016\/j.tox.2026.154466_bib13","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.3390\/ijms231911428","article-title":"Vitro Models for Studying Chronic Drug-Induced Liver Injury","volume":"23","author":"Donato","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cpt.2432","article-title":"Clinical and Molecular Perspectives on Inflammation-Mediated Regulation of Drug Metabolism and Transport","volume":"112","author":"Dunvald","year":"2022","journal-title":"Clin. Pharmacol. & Ther."},{"key":"10.1016\/j.tox.2026.154466_bib15","unstructured":"European Commission. (2020). European Commission\u2019s chemicals strategy for sustainability towards a toxic-free environment. \u3008https:\/\/environment.ec.europa.eu\/strategy\/chemicals-strategy_en\u3009."},{"issue":"5","key":"10.1016\/j.tox.2026.154466_bib16","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0021-9258(17)35917-3","article-title":"HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation","volume":"261","author":"Everson","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/dmd.117.078048","article-title":"The JAK1\/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes","volume":"46","author":"Febvre-James","year":"2018","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.tox.2026.154466_bib18","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/hep.24314","article-title":"Diclofenac inhibits tumor necrosis factor-\u03b1-induced nuclear factor-\u03baB activation causing synergistic hepatocyte apoptosis","volume":"53","author":"Fredriksson","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfu072","article-title":"Drug-Induced Endoplasmic Reticulum and Oxidative Stress Responses Independently Sensitize Toward TNF\u03b1-Mediated Hepatotoxicity","volume":"140","author":"Fredriksson","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.tox.2026.154466_bib20","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2026.154466_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tox.2026.154466_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxrep.2017.02.001","article-title":"Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: A pilot study","volume":"4","author":"Granitzny","year":"2017","journal-title":"Toxicol. Rep."},{"issue":"4","key":"10.1016\/j.tox.2026.154466_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01797915","article-title":"Detoxification pathways in the liver","volume":"14","author":"Grant","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.tox.2026.154466_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/tx300519p","article-title":"Human Precision-Cut Liver Slices as an ex Vivo Model to Study Idiosyncratic Drug-Induced Liver Injury","volume":"26","author":"Hadi","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.tox.2026.154466_bib25","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00204-022-03329-8","article-title":"Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations","volume":"96","author":"Hammour","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jgh3.12862","article-title":"Discontinuation of immunosuppression in patients with immune-mediated drug-induced liver injury or idiopathic autoimmune hepatitis: A case\u2013control study","volume":"7","author":"Hassoun","year":"2023","journal-title":"JGH Open"},{"key":"10.1016\/j.tox.2026.154466_bib27","doi-asserted-by":"crossref","unstructured":"Jaeschke, H. (2007). Kupffer cells. In Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd Edition (pp. 36\u201342).","DOI":"10.1002\/9780470691861.ch1e"},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40004-z","article-title":"Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model","volume":"13","author":"Kaden","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2026.154466_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tiv.2017.08.011","article-title":"Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state","volume":"45","author":"K\u00e4mpfer","year":"2017","journal-title":"Toxicol. Vitr."},{"issue":"6","key":"10.1016\/j.tox.2026.154466_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.chemrestox.7b00065","article-title":"Supernatant from hepatocyte cultures with drugs that cause idiosyncratic liver injury activates macrophage inflammasomes","volume":"30","author":"Kato","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/dmd.114.060962","article-title":"A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG Cells","volume":"43","author":"Klein","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.tox.2026.154466_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100241","article-title":"Interval-based secretomics unravels acute-phase response in hepatocyte model systems","volume":"21","author":"Knecht","year":"2022","journal-title":"Mol. & Cell. Proteom."},{"key":"10.1016\/j.tox.2026.154466_bib33","doi-asserted-by":"crossref","unstructured":"Krauser, J.A., Voehler, M., Tseng, L., Schefer, A.B., Godejohann, M., Guengerich, F.P., 2004. Testosterone 1\u03b2-hydroxylation by human cytochrome P450 3A4. European Journal of Biochemistry, 271(19), 3962\u20133969. https:\/\/doi.org\/10.1111\/j.1432-1033.2004.04339.x.","DOI":"10.1111\/j.1432-1033.2004.04339.x"},{"issue":"17","key":"10.1016\/j.tox.2026.154466_bib34","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","article-title":"Timing of new black box warnings and withdrawals for prescription medications","volume":"287","author":"Lasser","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/dmd.107.016907","article-title":"Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1\u03b2","volume":"36","author":"Le Vee","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.tox.2026.154466_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1289\/ehp.98106633","article-title":"Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen","volume":"106","author":"Lewis","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/toxsci\/kfr266","article-title":"Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha","volume":"125","author":"Lu","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.tox.2026.154466_bib38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jhep.2015.06.022","article-title":"Expression and functionality of Toll- and RIG-like receptors in HepaRG cells","volume":"63","author":"Luangsay","year":"2015","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.tox.2026.154466_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s002280050527","article-title":"A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism","volume":"54","author":"Lucas","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.tox.2026.154466_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.117.242354","article-title":"Synergistic cytotoxicity from drugs and cytokines in vitro as an approach to classify drugs according to their potential to cause idiosyncratic hepatotoxicity: a proof-of-concept study","volume":"362","author":"Maiuri","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.tox.2026.154466_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/acs.chemrestox.8b00091","article-title":"The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury","volume":"31","author":"Mak","year":"2018","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kfx219","article-title":"Editor\u2019s Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone\/Pioglitazone and Tolcapone\/Entacapone to Cause IDILI","volume":"161","author":"Mak","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.tox.2026.154466_bib43","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.chemrestox.5b00305","article-title":"The Combination of Anti-CTLA-4 and PD1\u2013\/\u2013 Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury","volume":"28","author":"Mak","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib44","doi-asserted-by":"crossref","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.tox.2026.154466_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/138920007779815986","article-title":"Transcriptional regulation and expression of CYP3A4 in Hepatocytes","volume":"8","author":"Martinez-Jimenez","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00204-012-0968-2","article-title":"Multi-cell type human liver microtissues for hepatotoxicity testing","volume":"87","author":"Messner","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2026.154466_bib47","doi-asserted-by":"crossref","DOI":"10.1063\/5.0051765","article-title":"Latest impact of engineered human liver platforms on drug development","volume":"5","author":"Monckton","year":"2021","journal-title":"APL Bioeng."},{"issue":"5","key":"10.1016\/j.tox.2026.154466_bib48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s13318-017-0406-1","article-title":"Effect of Gevokizumab on Interleukin-1\u03b2-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes","volume":"42","author":"Moreau","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.tox.2026.154466_bib49","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00365.2018","article-title":"Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism","volume":"316","author":"Nagarajan","year":"2019","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.tox.2026.154466_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096053","article-title":"Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli","volume":"9","author":"Norris","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cbi.2004.09.003","article-title":"Human and animal hepatocytes in vitro with extrapolation in vivo","volume":"150","author":"O\u2032Brien","year":"2004","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.tox.2026.154466_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/10408444.2016.1149452","article-title":"Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis","volume":"46","author":"Onakpoya","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2026.154466_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104957","article-title":"Indirect co-cultivation of HepG2 with differentiated THP-1 cells induces AHR signalling and release of pro-inflammatory cytokines","volume":"68","author":"Padberg","year":"2020","journal-title":"Toxicol. Vitr."},{"issue":"6","key":"10.1016\/j.tox.2026.154466_bib55","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-019-02457-y","article-title":"Minor structural modifications of bisphenol A strongly affect physiological responses of HepG2 cells","volume":"93","author":"Padberg","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2026.154466_bib56","doi-asserted-by":"crossref","unstructured":"Prieto, P., Baird, A.W., Blaauboer, B.J., Ripoll, J.V.C., Corvi, R., Dekant, W., Dietl, P., Gennari, A., Gribaldo, L., Griffin, J.L., Hartung, T., Heindel, J.J., Hoet, P., Jennings, P., Marocchio, L., Noraberg, J., Pazos, P., Westmoreland, C., Wolf, A., Pfaller, W., 2006. The Assessment of Repeated Dose Toxicity In Vitro: A Proposed Approach. Alternatives to Laboratory Animals, 34(3), 315\u2013341. https:\/\/doi.org\/10.1177\/026119290603400307.","DOI":"10.1177\/026119290603400307"},{"issue":"10","key":"10.1016\/j.tox.2026.154466_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/imcb.12590","article-title":"Selection and validation of reference genes for <scp>qPCR<\/scp> analysis of differentiation and maturation of <scp>THP<\/scp> -1 cells into <scp>M1<\/scp> macrophage-like cells","volume":"100","author":"Ren","year":"2022","journal-title":"Immunol. & Cell Biol."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.041624","article-title":"Inflammation and Drug Idiosyncrasy\u2014Is There a Connection?","volume":"307","author":"Roth","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/dmd.114.059246","article-title":"HepaRG Cells as Human-Relevant In Vitro Model to Study the Effects of Inflammatory Stimuli on Cytochrome P450 Isoenzymes","volume":"43","author":"Rubin","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.tox.2026.154466_bib60","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1021\/acs.chemrestox.5c00235","article-title":"Industry perspective on nonclinical approaches for hepatotoxicity risk assessment: insights from two longitudinal surveys conducted in 2023 and 2017","volume":"38","author":"Sakatis","year":"2025","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.tox.2026.154466_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/0929867013373435","article-title":"Adverse reactions to fluoroquinolones. an overview on mechanistic aspects","volume":"8","author":"Sarro","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2026.154466_bib62","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s40264-014-0182-7","article-title":"Evolution of the food and drug administration approach to liver safety assessment for new drugs: current status and challenges","volume":"37","author":"Senior","year":"2014","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2026.154466_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tox.2017.07.018","article-title":"The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective","volume":"389","author":"Sewell","year":"2017","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/toxsci\/kfn205","article-title":"Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma\u2013dependent liver injury","volume":"107","author":"Shaw","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.tox.2026.154466_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cpr.12030","article-title":"PMA withdrawal in PMA-treated monocytic THP-1 cells and subsequent retinoic acid stimulation, modulate induction of apoptosis and appearance of dendritic cells","volume":"46","author":"Spano","year":"2013","journal-title":"Cell Prolif."},{"key":"10.1016\/j.tox.2026.154466_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol. & Ther."},{"issue":"6","key":"10.1016\/j.tox.2026.154466_bib67","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/jat.4585","article-title":"Reactive metabolite of trovafloxacin activates inflammasomes: Implications for trovafloxacin-induced liver injury","volume":"44","author":"Tanaka","year":"2024","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.tox.2026.154466_bib68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389200033489398","article-title":"The metabolism of diclofenac - enzymology and toxicology perspectives","volume":"4","author":"Tang","year":"2003","journal-title":"Curr. Drug Metab."},{"issue":"7","key":"10.1016\/j.tox.2026.154466_bib69","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.3390\/ijms22073441","article-title":"Idiosyncratic drug induced liver injury, cytochrome P450, metabolic risk factors and lipophilicity: highlights and controversies","volume":"22","author":"Teschke","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.tox.2026.154466_bib70","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/diagnostics15131588","article-title":"Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms","volume":"15","author":"Teschke","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.tox.2026.154466_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.04.007","article-title":"Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis","volume":"302","author":"Tolosa","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2026.154466_bib72","first-page":"1","article-title":"DILI prediction in drug development: present and future","author":"Uetrecht","year":"2025","journal-title":"Expert Opin. Drug Metab. & Toxicol."},{"key":"10.1016\/j.tox.2026.154466_bib73","series-title":"New Insights into Toxicity and Drug Testing","article-title":"Pre-Clinical Assessment of the Potential Intrinsic Hepatotoxicity of Candidate Drugs","author":"van Tonder","year":"2013"},{"issue":"5","key":"10.1016\/j.tox.2026.154466_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00204-011-0711-4","article-title":"Towards an integrated in vitro strategy for repeated dose toxicity testing","volume":"85","author":"Vanhaecke","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2026.154466_bib75","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-\u03b1 or Interleukin-6","volume":"37","author":"Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"9\u201310","key":"10.1016\/j.tox.2026.154466_bib76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.drudis.2011.02.014","article-title":"The effect of inflammation on drug metabolism: a focus on pediatrics","volume":"16","author":"Vet","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.tox.2026.154466_bib77","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/antiox12071315","article-title":"Mechanistic Understanding of Idiosyncratic Drug-Induced Hepatotoxicity Using Co-Cultures of Hepatocytes and Macrophages","volume":"12","author":"Villanueva-Badenas","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.tox.2026.154466_bib78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.toxlet.2016.06.013","article-title":"What is the contribution of human FMO3 in the N -oxygenation of selected therapeutic drugs and drugs of abuse?","volume":"258","author":"Wagmann","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2026.154466_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ilar\/ilaa015","article-title":"Virtue Ethics and Laboratory Animal Research","author":"Walker","year":"2020","journal-title":"ILAR J."},{"issue":"8","key":"10.1016\/j.tox.2026.154466_bib80","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000208","article-title":"Hepatocytes reprogram liver macrophages involving control of TGF-\u03b2 activation, influencing liver regeneration and injury","volume":"7","author":"Wolf","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/SHK.0000000000000373","article-title":"Prolonged Endoplasmic Reticulum\u2013Stressed Hepatocytes Drive an Alternative Macrophage Polarization","volume":"44","author":"Xiu","year":"2015","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2026.154466_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105374","article-title":"Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization","volume":"82","author":"Yang","year":"2022","journal-title":"Toxicol. Vitr."},{"issue":"5","key":"10.1016\/j.tox.2026.154466_bib84","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, cryopreserved human hepatocytes, and HepG2 Cell Cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol. & Pharm. Bull."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. & Ther."},{"issue":"1","key":"10.1016\/j.tox.2026.154466_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.109.156331","article-title":"Sulindac metabolism and synergy with tumor necrosis factor-\u03b1 in a drug-inflammation interaction model of idiosyncratic liver injury","volume":"331","author":"Zou","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:49:34Z","timestamp":1778906974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X26000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":86,"alternative-id":["S0300483X26000739"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2026.154466","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of HepaRG mono- and HepaRG:THP-1 cocultures as immune responsive hepatotoxicity models","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2026.154466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154466"}}